News |

NCIRS releases new and updated FAQs resources

As the weather cools across Australia and new vaccines and treatments become available, NCIRS has published a suite of FAQs resources on three of the most common respiratory diseases in Australia: influenza, COVID-19 and respiratory syncytial virus (RSV).

Authored by NCIRS specialists and designed to support both immunisation providers and the general public, the resources are based on the latest expert research and Australian Technical Advisory Group on Immunisation (ATAGI) advice.

Access the FAQs:

Influenza

COVID-19

RSV



News & events

News |

Towards eliminating cervical cancer – tracking HPV vaccination progress in LMICs
News |

New study explores the communication needs of Australian pharmacist immunisers
News |

Fieldwork completed for hexavalent vaccine post-introduction evaluation in Fiji
News |

More pharmacists will be able to vaccinate children under 5. Here’s what you need to know
News |

50 Years of Deadly: why NAIDOC Week 2026 matters for immunisation

News |

NCIRS visit to China strengthens collaboration on HPV vaccination
News |

Aboriginal and Torres Strait Islander Immunisation Leadership Committee meet to shape priorities for the year ahead
News |

Australia is battling its worst diphtheria outbreak in decades. But vaccines could curb it
News |

NCIRS study finds serious recurrent complications after TTS are rare, but persistent symptoms affecting physical and mental health are common
News |

Poliovirus detected in wastewater in Australia
All news & events